Cite

HARVARD Citation

    Gentile, M. et al. (2018). Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment. European journal of haematology. pp. 703-706. [Online]. 
  
Back to record